M. Garcia

发表

Switching From the Original to the Biosimilar Recombinant Human GH - Omnitrope[reg]: an Experience of a Single Paediatric Centre in Spain

A. Gila, M. Garcia, 2014 .

P2.06-010 AZD9291 as 1st-Line Therapy for EGFR Mutant NSCLC Patients with Concomitant Pretreatment EGFR T790M Mutation. The AZENT Study: Topic: Phase II + NK

R. Rosell, N. Karachaliou, J. Sánchez, 2017 .